Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by eczematous lesions and pruritus. Pruritus can lead to exacerbation of disease and reduced quality of life (QoL). Crisaborole ointment is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate AD. Compared with vehicle, use of crisaborole significantly reduced global disease severity and pruritus in 2 large, identically designed phase 3 clinical studies (AD-301: NCT02118766; AD-302: NCT02118792).
Δευτέρα 13 Αυγούστου 2018
Relationship between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.